Streetbeat News

Stock Prices

PRSO

Peraso Inc. (NASDAQ: PRSO) has announced a new customer partnership for its X130 chipset, signaling growth and expansion into high-volume consumer markets. The X130 chipset, featuring the PRS1145 and PRS4601 ICs, will be used for wireless video distribution, replacing the customer's existing solution. It supports high bandwidth and low latency applications, avoiding Wi-Fi congestion by using mmWave technology. The X130 is designed for applications like wireless AR/VR, displays, docking, and cloud access, and includes advanced features such as beamforming, beam tracking, and AES security.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:03 pm

ORCL

BMO Capital analyst Keith Bachman has maintained a 'Market Perform' rating on Oracle (NYSE:ORCL) but has reduced the price target from $130 to $126.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:02 pm

SHOP

DZ Bank analyst Axel Herlinghaus has downgraded Shopify (NYSE:SHOP) from Hold to Sell and set a new price target of $65.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:01 pm

BSX

TD Cowen analyst Joshua Jennings has reaffirmed an Outperform rating on Boston Scientific (NYSE:BSX) and increased the price target from $58 to $65, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:00 pm

ABNB

ACHV

ADBE

AMGN

GPRO

HPQ

ORCL

PVH

SEMR

VEL

Wall Street analysts have updated their price targets and ratings for several US-listed companies. BTIG raised Velocity Financial's target from $14 to $17 with a Buy rating. Citigroup increased Adobe's target from $610 to $675, maintaining a Neutral rating. Oppenheimer lowered Achieve Life Sciences' target from $21 to $18 but kept an Outperform rating. Needham raised Semrush's target from $13 to $15 with a Buy rating. Barclays downgraded Airbnb from Equal-Weight to Underweight, reducing the target from $135 to $100. RBC Capital upgraded Amgen from Sector Perform to Outperform, raising the target from $256 to $300. Morgan Stanley downgraded GoPro from Equal-Weight to Underweight, cutting the target from $4 to $3. The same analyst upgraded HP from Equal-Weight to Overweight, increasing the target from $31 to $35. Piper Sandler maintained an Overweight rating on Oracle but reduced the target from $130 to $125. Telsey Advisory Group raised PVH Corp's target from $111 to $122 with an Outperform rating.

Portfolio Pulse from Avi Kapoor

December 12, 2023 | 1:00 pm

EVER

EverQuote (NASDAQ:EVER) has received 4 analyst ratings in the last quarter, with 3 being bullish and 1 somewhat bullish. There have been no indifferent, somewhat bearish, or bearish ratings. The average price target is $13.25, representing an upside from the current price of $10.18. This target has increased by 65.62% from the previous target of $8.00. Analysts rate stocks typically once a quarter and provide forecasts on various financial metrics.

Portfolio Pulse from Benzinga Insights

December 12, 2023 | 1:00 pm

AMAT

Over the past 3 months, 10 Wall Street analysts have provided ratings for Applied Materials (NASDAQ:AMAT), with 5 bullish, 3 somewhat bullish, and 2 indifferent. The average 12-month price target for AMAT is $169.2, with a high of $185.00 and a low of $142.00. This target has increased by 11.17% over the past month. Analysts rate stocks based on research and forecasts, and these ratings can influence trading decisions.

Portfolio Pulse from Benzinga Insights

December 12, 2023 | 1:00 pm

HCDI

ICVX

ORCL

Icosavax, Inc. (NASDAQ:ICVX) shares surged approximately 45% in pre-market trading following AstraZeneca's announcement of plans to acquire Icosavax for up to $1.1 billion. Icosavax also reported positive interim Phase 2 results for its IVX-A12 vaccine candidate. Other stocks experiencing pre-market movements include gainers Bruush Oral Care Inc. (BRSH), Connect Biopharma Holdings Limited (CNTB), and losers Harbor Custom Development, Inc. (HCDI), which filed for Chapter 11 bankruptcy, and Oracle Corporation (ORCL), which reported mixed quarterly results.

Portfolio Pulse from Avi Kapoor

December 12, 2023 | 1:00 pm

NTRA

TD Cowen analyst Dan Brennan has reaffirmed an Outperform rating on Natera (NASDAQ:NTRA) and increased the price target from $82 to $87, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:58 pm

NOV

TD Cowen analyst Marc Bianchi has maintained an Outperform rating on NOV Inc. (NYSE:NOV) and increased the price target from $28 to $29.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:55 pm